Randomized Trial of Safety and Effectiveness of Chlorproguanil-Dapsone and Lumefantrine-Artemether for Uncomplicated Malaria in Children in The Gambia

Treatment with Coartem (Artemether-Lumefantrine) in Papua New Guinea

(2010) Sonja Schoepflin et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

(2010) Lucio Luzzatto   LANCET

Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility

(2009) Taane G Clark et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria

(2009) Zul Premji et al.   PLoS One

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

(2008) Salim Abdulla et al.   LANCET

High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency

(2008) Caterina I. Fanello et al.   PLoS One